Published in Self Nonself on March 06, 2010
SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing. PLoS One (2012) 0.82
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control. Sci Rep (2017) 0.77
High diversification of CD94 by alternative splicing in New World primates. Immunogenetics (2013) 0.75
Natural killer cells in healthy and diseased subjects. J Biomed Biotechnol (2011) 0.75
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A (2000) 11.51
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature (2005) 7.18
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07
Placental mammal diversification and the Cretaceous-Tertiary boundary. Proc Natl Acad Sci U S A (2003) 6.29
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol (2001) 5.48
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity (2001) 5.42
Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science (1995) 5.41
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol (2006) 5.00
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (2001) 4.93
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 4.76
Patterns of positive selection in six Mammalian genomes. PLoS Genet (2008) 4.69
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 4.69
An activating immunoreceptor complex formed by NKG2D and DAP10. Science (1999) 4.56
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 4.40
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med (2002) 4.32
Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 4.24
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 4.14
The dynamic life of natural killer cells. Annu Rev Immunol (2004) 3.96
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity (2000) 3.84
Self-tolerance of natural killer cells. Nat Rev Immunol (2006) 3.75
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity (1995) 3.72
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A (2007) 3.60
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med (1997) 3.57
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature (2000) 3.54
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity (1997) 3.43
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A (1998) 3.35
A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1994) 3.33
Immune functions encoded by the natural killer gene complex. Nat Rev Immunol (2003) 3.21
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med (1998) 3.09
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med (1999) 3.08
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med (1998) 2.87
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol (2005) 2.55
Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol (2001) 2.43
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood (2005) 2.31
The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol (2003) 2.29
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol (2002) 2.26
Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol (2001) 2.25
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med (2005) 2.23
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity (2007) 2.20
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med (1999) 2.17
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol (1997) 2.09
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood (2003) 2.06
The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity (1999) 2.04
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99
The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol (1998) 1.97
The genomic context of natural killer receptor extended gene families. Immunol Rev (2001) 1.92
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol (2003) 1.86
Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet (2005) 1.85
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol (1997) 1.84
The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. Structure (2003) 1.82
Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A (2006) 1.78
Primate jumping genes elucidate strepsirrhine phylogeny. Proc Natl Acad Sci U S A (2004) 1.78
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol (2003) 1.78
Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity (2003) 1.77
Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol (2007) 1.71
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol (1997) 1.69
Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nat Rev Immunol (2009) 1.68
NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A (2005) 1.67
IPD--the Immuno Polymorphism Database. Nucleic Acids Res (2005) 1.60
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol (1998) 1.60
DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J Exp Med (2000) 1.59
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (2010) 1.59
Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res (2005) 1.56
Common themes in the assembly and architecture of activating immune receptors. Nat Rev Immunol (2007) 1.54
The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci U S A (2005) 1.54
Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J Immunol (2004) 1.51
Origins of HIV and the evolution of resistance to AIDS. Science (2006) 1.49
Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol (1994) 1.47
ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun (2003) 1.47
The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol (1999) 1.47
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med (2008) 1.40
Novel humanized murine models for HIV research. Curr HIV/AIDS Rep (2009) 1.40
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol (2004) 1.40
Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity (2003) 1.36
MIC genes: from genetics to biology. Adv Immunol (2000) 1.36
Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol (2005) 1.35
Towards a small animal model for hepatitis C. EMBO Rep (2009) 1.34
NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C. J Immunol (2002) 1.32
MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol (2001) 1.31
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol (1996) 1.29
Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J Immunol (2007) 1.28
A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics (2002) 1.28
Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J Immunol (2008) 1.27
Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J Biochem (1996) 1.27
Breast implant infections after surgical reconstruction in patients with breast cancer: assessment of risk factors and pathogens over extended post-operative observation. Surg Infect (Larchmt) (2012) 2.04
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol (2004) 1.53
Trends in HIV, gonorrhoea, and syphilis. Screening for neurosyphilis is recommended. BMJ (2002) 1.38
Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol (2002) 1.22
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol (2011) 1.19
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol (2011) 1.11
Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol (2011) 1.10
Absence of HIV-1 after treatment cessation in an infant. N Engl J Med (2014) 1.10
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci U S A (2013) 1.07
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med (2013) 1.03
Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. Cytometry A (2013) 0.98
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. Int Immunol (2009) 0.96
CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection. Eur J Immunol (2010) 0.95
Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection. J Immunol (2005) 0.93
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients. AIDS (2003) 0.90
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. Immunol Lett (2013) 0.87
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. Eur J Immunol (2002) 0.86
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma. Neuro Oncol (2011) 0.86
Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals. J Immunol (2007) 0.85
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. Int Immunol (2011) 0.84
Natural killer cells in hepatitis C virus infection. Expert Rev Clin Immunol (2012) 0.83
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. J Immunol (2005) 0.83
NKp44 expression, phylogenesis and function in non-human primate NK cells. Int Immunol (2009) 0.82
High rate of Quantiferon positive and tuberculin negative tests in infants born at a large Italian university hospital in 2011: a cautionary hypothesis. Pathog Glob Health (2012) 0.81
Troubleshooting fine-tuning procedures for qPCR system design. J Clin Lab Anal (2011) 0.80
HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays. Trop Med Int Health (2008) 0.80
NK cell receptors and their interactions with MHC. Curr Pharm Des (2009) 0.79
Discordant responses to HAART in HIV-1 patients: the need to focus on intervention. Expert Rev Anti Infect Ther (2007) 0.79
The role of Pneumococcal vaccine. Pulm Pharmacol Ther (2008) 0.78
Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG). Eur J Immunol (2012) 0.78
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. Eur J Immunol (2009) 0.78
Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy. BMC Infect Dis (2013) 0.77
HLA-B and HLA-C Supratyping by Pyrosequencing®. Methods Mol Biol (2015) 0.77
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era. Int J Hematol (2010) 0.77
Clinically stable treatment-experienced adults receiving tenofovir and didanosine. HIV Clin Trials (2006) 0.77
Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to West. J Neurosurg Sci (2016) 0.77
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients. J Clin Virol (2012) 0.76
Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients. Int J Antimicrob Agents (2010) 0.76
Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus. J Transl Med (2015) 0.76
May immunization strategies that target dendritic cells really offer advantages for HIV-1? AIDS (2006) 0.75
Reply to Silvestri et al. Surg Infect (Larchmt) (2013) 0.75
Chronic obstructive pulmonary disease, antibiotics, and prediction of bacterial infection. Clin Infect Dis (2005) 0.75
Important factors to consider for patients with community-acquired pneumonia. Clin Infect Dis (2005) 0.75
Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. AIDS (2014) 0.75
Early active tuberculosis in gold miners who undergo HIV seroconversion: should it influence general practice? J Infect Dis (2005) 0.75
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy. Infection (2017) 0.75
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children. Int J Antimicrob Agents (2006) 0.75
Tubercular tracheoesophageal fistulas in AIDS patients: primary repair and no surgery required? AIDS (2007) 0.75
Revisited function of human NK cell subsets. Cell Cycle (2011) 0.75
Unusual presentation of visceral leishmaniasis in an HIV-infected patient. AIDS Res Hum Retroviruses (2014) 0.75
Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin. J Clin Virol (2010) 0.75
Efficacy of a Checklist for Office-Laboratory Communication: A Clinical Study on Quality Outcomes for Single Crowns. Int J Prosthodont (2017) 0.75